Published in Eur J Surg Oncol on April 01, 1988
c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer (1991) 1.37
Oncogenes and human breast cancer. Am J Hum Genet (1989) 1.29
Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer? Cancers (Basel) (2014) 0.92
Prognostic value of c-erbB-2 expression in uterine cervical carcinoma. J Clin Pathol (1992) 0.83
p185, an immunodominant epitope, is an autoantigen mimotope. J Biol Chem (2011) 0.75
Wnt signaling: a common theme in animal development. Genes Dev (1997) 12.94
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell (1982) 9.29
Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol (1998) 9.24
A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature (1996) 7.04
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature (1984) 5.53
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med (1988) 4.06
Information access. Building a "GenBank" of the published literature. Science (2001) 3.95
Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res (1988) 3.91
The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell (1987) 3.78
Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev (1998) 3.65
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature (2001) 3.57
A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature (1999) 3.22
Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity (2000) 3.19
K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med (1990) 3.16
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement. Lancet (1998) 3.06
Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med (1987) 3.04
Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol Cell Biol (1987) 2.96
Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol (1994) 2.92
Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex. Genes Dev (1999) 2.78
Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol (2008) 2.73
Ductal carcinoma in-situ of the breast; second EORTC consensus meeting. Eur J Cancer (1992) 2.67
[The treatment of ductal carcinoma in situ (DCIS) of the breast]. Ned Tijdschr Geneeskd (2003) 2.67
Distribution of the wingless gene product in Drosophila embryos: a protein involved in cell-cell communication. Cell (1989) 2.61
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol (2001) 2.51
The Drosophila segment polarity gene dishevelled encodes a novel protein required for response to the wingless signal. Genes Dev (1994) 2.50
The dishevelled protein is modified by wingless signaling in Drosophila. Genes Dev (1995) 2.46
BRAF(E600) in benign and malignant human tumours. Oncogene (2007) 2.45
Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact. Cell (1984) 2.44
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer (2003) 2.40
[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"]. Ned Tijdschr Geneeskd (2002) 2.39
dishevelled and armadillo act in the wingless signalling pathway in Drosophila. Nature (1994) 2.29
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol (2001) 2.28
Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party. J Pathol (1997) 2.28
Wingless repression of Drosophila frizzled 2 expression shapes the Wingless morphogen gradient in the wing. Cell (1998) 2.23
Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene (1992) 2.22
Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene (2001) 2.21
Biological activity of soluble wingless protein in cultured Drosophila imaginal disc cells. Nature (1994) 2.20
Naked cuticle targets dishevelled to antagonize Wnt signal transduction. Genes Dev (2001) 2.16
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol (1997) 2.15
WNT signaling in the control of hair growth and structure. Dev Biol (1999) 2.13
Mutations in the segment polarity genes wingless and porcupine impair secretion of the wingless protein. EMBO J (1993) 2.12
Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008. Br J Dermatol (2012) 2.03
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer (1997) 2.02
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. Eur Respir J (2009) 2.01
Casein kinase 2 associates with and phosphorylates dishevelled. EMBO J (1997) 1.97
Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain. Proc Natl Acad Sci U S A (1990) 1.94
Wnts as ligands: processing, secretion and reception. Oncogene (2006) 1.90
Isolation and characterization of a mouse homolog of the Drosophila segment polarity gene dishevelled. Dev Biol (1994) 1.89
Mammary tumor induction loci in GR and DBAf mice contain one provirus of the mouse mammary tumor virus. Cell (1981) 1.89
The impact of tumor size and histology on local control after breast-conserving therapy. Radiother Oncol (1988) 1.83
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up. Ann Oncol (2002) 1.80
Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg (2000) 1.71
Expression of two members of the Wnt family during mouse development--restricted temporal and spatial patterns in the developing neural tube. Genes Dev (1991) 1.69
Tissue distribution of the human MDR3 P-glycoprotein. Lab Invest (1994) 1.69
Transfection of the int-1 mammary oncogene in cuboidal RAC mammary cell line results in morphological transformation and tumorigenicity. EMBO J (1987) 1.69
A new nomenclature for int-1 and related genes: the Wnt gene family. Cell (1991) 1.67
Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst (1991) 1.64
A Drosophila Axin homolog, Daxin, inhibits Wnt signaling. Development (1999) 1.61
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST) Eur J Cancer (1999) 1.55
Structural analysis of a 1.7-kilobase mouse mammary tumor virus-specific RNA. J Virol (1983) 1.55
Signaling by wingless in Drosophila. Dev Biol (1994) 1.53
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res (1992) 1.53
The consequences of ubiquitous expression of the wingless gene in the Drosophila embryo. Development (1992) 1.52
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome. Br J Cancer (2003) 1.50
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Eur J Cancer (2000) 1.50
Lymph node metastasis from melanoma with an unknown primary site. Br J Surg (1990) 1.49
Pathway specificity by the bifunctional receptor frizzled is determined by affinity for wingless. Mol Cell (2000) 1.49
Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene (2009) 1.48
Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int J Cancer (1991) 1.47
Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer (1999) 1.46
Validation of 70-gene prognosis signature in node-negative breast cancer. Breast Cancer Res Treat (2008) 1.45
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol (2001) 1.44
The int genes in mammary tumorigenesis and in normal development. Trends Genet (1988) 1.43
The status of Wnt signalling regulates neural and epidermal fates in the chick embryo. Nature (2001) 1.43
[Diagnostics in clinically occult, radiologically suspect breast lesions more often surgery than needle diagnostics with image monitoring]. Ned Tijdschr Geneeskd (2001) 1.43
[Identification of the sentinel node in patients with breast carcinoma]. Ned Tijdschr Geneeskd (1996) 1.42
[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer]. Ned Tijdschr Geneeskd (2004) 1.40
[Tumor markers in screening, diagnosis and treatment of patients with breast carcinoma]. Ned Tijdschr Geneeskd (1993) 1.38
Translation of mouse mammary tumor virus RNA: precursor polypeptides are phosphorylated during processing. Virology (1978) 1.38
The Frizzled CRD domain is conserved in diverse proteins including several receptor tyrosine kinases. Curr Biol (1998) 1.35
Frizzled and Dfrizzled-2 function as redundant receptors for Wingless during Drosophila embryonic development. Development (1999) 1.34
The nucleotide sequence of the human int-1 mammary oncogene; evolutionary conservation of coding and non-coding sequences. EMBO J (1985) 1.34
Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein-Barr virus infection. Histopathology (2001) 1.32
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer (2003) 1.31
Activation of int-1 and int-2 mammary oncogenes in hormone-dependent and -independent mammary tumors of GR mice. J Virol (1987) 1.29
Diagnosis of thin melanoma. J Clin Pathol (1997) 1.28
Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma. Histopathology (2005) 1.27
Involvement of mouse mammary tumor virus in spontaneous and hormone-induced mammary tumors in low-mammary-tumor mouse strains. J Virol (1978) 1.26
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch (1999) 1.24
Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study. Virchows Arch (2000) 1.24
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer (2001) 1.22
MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review. Skeletal Radiol (2000) 1.21
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma. Histopathology (2007) 1.21
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res (1994) 1.21
No common denominator for breast cancer lymph node metastasis. Br J Cancer (2005) 1.20